Mutations within the cGMP-binding domain of CNGA1 causing autosomal recessive retinitis pigmentosa in human and animal model.
Dinesh Kumar KandaswamyLena ZobelBina JohnSathiyavedu Thyagarajan SanthiyaJacqueline BogedeinGerhard K H PrzemeckValérie Gailus-DurnerHelmut FuchsMartin BielMartin Hrabĕ de AngelisJochen GrawStylianos MichalakisOana Veronica AmariePublished in: Cell death discovery (2022)
Retinitis pigmentosa is a group of progressive inherited retinal dystrophies that may present clinically as part of a syndromic entity or as an isolated (nonsyndromic) manifestation. In an Indian family suffering from retinitis pigmentosa, we identified a missense variation in CNGA1 affecting the cyclic nucleotide binding domain (CNBD) and characterized a mouse model developed with mutated CNBD. A gene panel analysis comprising 105 known RP genes was used to analyze a family with autosomal-recessive retinitis pigmentosa (arRP) and revealed that CNGA1 was affected. From sperm samples of ENU mutagenesis derived F 1 mice, we re-derived a mutant with a Cnga1 mutation. Homozygous mutant mice, developing retinal degeneration, were examined for morphological and functional consequences of the mutation. In the family, we identified a rare CNGA1 variant (NM_001379270.1) c.1525 G > A; (p.Gly509Arg), which co-segregated among the affected family members. Homozygous Cnga1 mice harboring a (ENSMUST00000087213.12) c.1526 A > G (p.Tyr509Cys) mutation showed progressive degeneration in the retinal photoreceptors from 8 weeks on. This study supports a role for CNGA1 as a disease gene for arRP and provides new insights on the pathobiology of cGMP-binding domain mutations in CNGA1-RP.
Keyphrases
- wild type
- intellectual disability
- optical coherence tomography
- diabetic retinopathy
- mouse model
- high fat diet induced
- genome wide
- multiple sclerosis
- nitric oxide
- endothelial cells
- copy number
- genome wide identification
- dna binding
- optic nerve
- type diabetes
- dna methylation
- binding protein
- insulin resistance
- metabolic syndrome
- induced pluripotent stem cells
- gestational age